金域医学：预计2025年上半年净利润亏损6500万元-9500万元

Core Viewpoint - Kingmed Diagnostics (603882) is expected to report a net profit attributable to shareholders of the listed company ranging from -65 million to -95 million yuan for the first half of 2025, indicating a shift from profit to loss compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -78 million and -110 million yuan for the first half of 2025 [1]